Arbor Biotechnologies Company
Arbor Biotechnologies is an operator of a bio-discovery company intended to provide human diagnostic development services. The company's platform employs a diverse set of technologies and techniques including artificial intelligence, genome sequencing, gene synthesis, and high-throughput screening, enabling drug developers to accelerate the discovery of proteins for improving human health and sustainability.
.png)
Technology:
Biopharma, Biotechnology, Life Science
Industry:
Early Drug Development
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2016-01-01
Employees Number:
51-100
Funding Status:
Early Stage Venture
Investors Number:
21
Total Funding:
230600000
Estimated Revenue:
Less than $1M
Last Funding Date:
2021-11-09
Last Funding Type:
Series B
Register and Claim Ownership